Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase

R. M. Bergenstal, W. V. Tamborlane, Andrew Ahmann, J. B. Buse, G. Dailey, S. N. Davis, C. Joyce, B. A. Perkins, J. B. Welsh, S. M. Willi, M. A. Wood

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalDiabetes Technology and Therapeutics
Volume15
Issue numberSUPPL.1
DOIs
StatePublished - Jun 1 2013
Externally publishedYes

Fingerprint

Therapeutics

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., ... Wood, M. A. (2013). Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase. Diabetes Technology and Therapeutics, 15(SUPPL.1). https://doi.org/10.1089/dia.2013.1512

Sensor-augmented pump therapy for A1C reduction (STAR 3) study : Results from the 6-month continuation phase. / Bergenstal, R. M.; Tamborlane, W. V.; Ahmann, Andrew; Buse, J. B.; Dailey, G.; Davis, S. N.; Joyce, C.; Perkins, B. A.; Welsh, J. B.; Willi, S. M.; Wood, M. A.

In: Diabetes Technology and Therapeutics, Vol. 15, No. SUPPL.1, 01.06.2013.

Research output: Contribution to journalArticle

Bergenstal, RM, Tamborlane, WV, Ahmann, A, Buse, JB, Dailey, G, Davis, SN, Joyce, C, Perkins, BA, Welsh, JB, Willi, SM & Wood, MA 2013, 'Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase', Diabetes Technology and Therapeutics, vol. 15, no. SUPPL.1. https://doi.org/10.1089/dia.2013.1512
Bergenstal, R. M. ; Tamborlane, W. V. ; Ahmann, Andrew ; Buse, J. B. ; Dailey, G. ; Davis, S. N. ; Joyce, C. ; Perkins, B. A. ; Welsh, J. B. ; Willi, S. M. ; Wood, M. A. / Sensor-augmented pump therapy for A1C reduction (STAR 3) study : Results from the 6-month continuation phase. In: Diabetes Technology and Therapeutics. 2013 ; Vol. 15, No. SUPPL.1.
@article{4d069941ca7441e89b2978e493cb07af,
title = "Sensor-augmented pump therapy for A1C reduction (STAR 3) study: Results from the 6-month continuation phase",
author = "Bergenstal, {R. M.} and Tamborlane, {W. V.} and Andrew Ahmann and Buse, {J. B.} and G. Dailey and Davis, {S. N.} and C. Joyce and Perkins, {B. A.} and Welsh, {J. B.} and Willi, {S. M.} and Wood, {M. A.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1089/dia.2013.1512",
language = "English (US)",
volume = "15",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "SUPPL.1",

}

TY - JOUR

T1 - Sensor-augmented pump therapy for A1C reduction (STAR 3) study

T2 - Results from the 6-month continuation phase

AU - Bergenstal, R. M.

AU - Tamborlane, W. V.

AU - Ahmann, Andrew

AU - Buse, J. B.

AU - Dailey, G.

AU - Davis, S. N.

AU - Joyce, C.

AU - Perkins, B. A.

AU - Welsh, J. B.

AU - Willi, S. M.

AU - Wood, M. A.

PY - 2013/6/1

Y1 - 2013/6/1

UR - http://www.scopus.com/inward/record.url?scp=84896831943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896831943&partnerID=8YFLogxK

U2 - 10.1089/dia.2013.1512

DO - 10.1089/dia.2013.1512

M3 - Article

AN - SCOPUS:84896831943

VL - 15

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - SUPPL.1

ER -